![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 491/048 | |
A61K 31/4355 | |||
A61P 3/04 | |||
A61P 25/18 | |||
A61P 25/22 | |||
A61P 25/28 |
(11) | Number of the document | 2146997 |
(13) | Kind of document | T |
(96) | European patent application number | 08742647.4 |
Date of filing the European patent application | 2008-04-07 | |
(97) | Date of publication of the European application | 2010-01-27 |
(45) | Date of publication and mention of the grant of the patent | 2010-11-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2008/004533 |
Date | 2008-04-07 |
(87) | Number | WO 2008/127585 |
Date | 2008-10-23 |
(30) | Number | Date | Country code |
922851 P | 2007-04-11 | US |
(72) |
CLEMENTS, Matthew, J., US
DEBENHAM, John, S., US
HALE, Jeffrey, J., US
MADSEN-DUGGAN, Christina, B., US
WALSH, Thomas, F., US
PERESYPKIN, Andrey, V., US
HELMY, Roy, US
|
(73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
(54) | SUBSTITUTED FURO[2,3-B]PYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS |
SUBSTITUTED FURO[2,3-B]PYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS |